StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BCAB

BioAtla, Inc.

BCAB Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$3.26
-0.03 -0.91%

Key statistics

from XBRL data in SEC filings
Market cap
$4.90M
Revenue (TTM)
$0.00
Net income (TTM)
$68.6M
EPS (TTM)
$7.93
P/E ratio
0.4
Dividend yield
Free cash flow
Cash
$1.96M
Total assets
$8.57M
Gross margin
52-week range
$3.12 – $71.50

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jul 16, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 29, 2026 8-K Other events Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2026 8-K Director or officer change; Shareholder vote results Mar 23, 2026 8-K Results of operations (earnings release); Exit or disposal costs; Director or officer change; Regulation FD disclosure; Other events Mar 2, 2026 8-K Other events Feb 9, 2026 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Feb 6, 2026 8-K Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure; Other events Jan 30, 2026 8-K Unregistered sale of equity; Amended charter or bylaws; Shareholder vote results; Other events Jan 12, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 31, 2025 8-K Shareholder vote results; Other events Dec 30, 2025 8-K Entered a material agreement; Took on a direct financial obligation Nov 21, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Other events Sep 22, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Director or officer change; Shareholder vote results Jun 20, 2025 8-K Delisting notice or listing-rule failure May 16, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release); Exit or disposal costs Mar 27, 2025 8-K Director or officer change Mar 14, 2025 8-K Delisting notice or listing-rule failure Feb 7, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 20, 2024 8-K Regulation FD disclosure Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Entered a material agreement Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 13, 2024 8-K Other events May 17, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 8-K Amended charter or bylaws Apr 24, 2024